2nd Annual

Metabolic Medicine Summit 2026

|


view programarrow icon

Discover the highlights of the event

connect with usarrow icon

Get your questions answered by our team

become a partnerarrow icon

Join as a sponsor and reserve your booth

Meet Our Featured Speakers

Megan Kirk Chang

Megan Kirk Chang

University of Oxford

Close icon
Steve Winshel

Steve Winshel

Paraxis

Megan Kirk Chang

Megan Kirk Chang

University of Oxford

Madhu Malo

Madhu Malo

Stapgen LLC

THE FORUM FOR METABOLIC MEDICINE AND TREATMENT DEVELOPMENT

Welcome to the Metabolic Medicine Summit 2026, an event that brings together industry leaders and healthcare innovators committed to advancing metabolic therapies, technologies, and clinical strategies that are shaping the future of metabolic health.

Metabolic medicine faces significant challenges in turning advancements in gene editing, biomarkers, and precision therapies into meaningful clinical outcomes. This summit will highlight innovative approaches that aim to improve patient care and treatment.

Join us to gain practical insights, connect with global leaders, and help shape the future of metabolic health through innovation and collaboration.

key topics for

Emerging trends in metabolic therapies and patient-centered care

Innovative precision therapies targeting individual metabolic needs, along with patient-centered care models, are transforming treatment strategies worldwide.

Advancing biomarker-based research to enhance clinical outcomes

Biomarker research supports precise, effective treatments by identifying disease-specific markers that enhance outcomes and personalize care.

Case studies and clinical trials on therapies for metabolic disorders

Clinical trial data and case studies demonstrate the safety, effectiveness, and real-world impact of emerging therapies for metabolic disorders.

Breakthrough in therapeutic approaches for obesity and metabolic disorders

Advanced therapies for obesity and related metabolic dysfunctions using emerging drug platforms to improve health outcomes.

Innovations in biosimilars and peptide drugs for advanced treatments

Biosimilars and peptides provide cost-effective alternatives, as well as innovative therapies, for managing complex metabolic disorders.

Shaping metabolic medicine with global compliance and regulatory standards

New guidelines ensure the safety, effectiveness, and quality of metabolic therapies, aligning treatment practices with global standards to improve patient care and outcomes.

0

INDUSTRY TOPICS

0

NETWORKING EVENTS

0

LEADING EXPERTS

0

Q&A SESSIONS

Latest News

  • INNOVATION

    8 Apr 2026

    A Weight-Loss Pill Without the Strings Attached
  • PARTNERSHIPS

    7 Apr 2026

    Insilico Does the Math, Lilly Writes the Check
  • INVESTMENT

    6 Apr 2026

    Meet the Startup Trying to Out-Ozempic Ozempic
  • PARTNERSHIPS

    31 Mar 2026

    The Shot Is So Last Year. Lilly Wants You to Pop a Pill

Wegovy Turns Up the Dial and Takes Aim at Lilly

Wegovy FlexTouch injection pens labeled 0.25 mg and 1 mg doses

REGULATORY

26 Mar 2026

The FDA approved Novo Nordisk's 7.2 mg Wegovy HD in 54 days, with trial data showing 20.7% average weight loss

they've attended our events

Image 1Image 2
Image 1Image 2
Image 1Image 2
Image 1Image 2

Expert Speakers

Vanessa Navarro

Danaher Corporation

Arjun Channi

Sanofi

Gulen Tonga

Tessera Therapeutics

Show more Speakers

Past Attendees

Danaher Corporation

Sanofi

Becton Dickinson

Tessera Therapeutics

Charles River

Inovio

Seran BioScience

Körber

Chiesi USA, Inc.

Show more Attendees

hidden text

subscribe for updates

hidden text

related events in the series